Viatris, Inc. (VTRS)
16.54
+0.22
(+1.38%)
USD |
NASDAQ |
Aug 24, 16:00
16.54
0.00 (0.00%)
After-Hours: 20:00
Viatris Debt to Equity Ratio : 0.9555 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.9555 |
| March 31, 2026 | 0.997 |
| December 31, 2025 | 0.9993 |
| September 30, 2025 | 0.9675 |
| June 30, 2025 | 0.9483 |
| March 31, 2025 | 0.9243 |
| December 31, 2024 | 0.7681 |
| September 30, 2024 | 0.8095 |
| June 30, 2024 | 0.8903 |
| March 31, 2024 | 0.9103 |
| December 31, 2023 | 0.898 |
| September 30, 2023 | 0.893 |
| June 30, 2023 | 0.9046 |
| March 31, 2023 | 0.9098 |
| December 31, 2022 | 0.9271 |
| September 30, 2022 | 1.056 |
| June 30, 2022 | 1.074 |
| March 31, 2022 | 1.091 |
| December 31, 2021 | 1.141 |
| September 30, 2021 | 1.124 |
| June 30, 2021 | 1.165 |
| March 31, 2021 | 1.156 |
| December 31, 2020 | 1.140 |
| September 30, 2020 | 1.001 |
| June 30, 2020 | 1.057 |
| Date | Value |
|---|---|
| March 31, 2020 | 1.147 |
| December 31, 2019 | 1.088 |
| September 30, 2019 | 1.162 |
| June 30, 2019 | 1.142 |
| March 31, 2019 | 1.179 |
| December 31, 2018 | 1.139 |
| September 30, 2018 | 1.199 |
| June 30, 2018 | 1.208 |
| March 31, 2018 | 1.148 |
| December 31, 2017 | 1.106 |
| September 30, 2017 | 1.107 |
| June 30, 2017 | 1.168 |
| March 31, 2017 | 1.289 |
| December 31, 2016 | 1.398 |
| September 30, 2016 | 1.324 |
| June 30, 2016 | 1.290 |
| March 31, 2016 | 0.7195 |
| December 31, 2015 | 0.7472 |
| September 30, 2015 | 0.6469 |
| June 30, 2015 | 0.8806 |
| March 31, 2015 | 0.9326 |
| December 31, 2014 | 2.601 |
| September 30, 2014 | 2.386 |
| June 30, 2014 | 2.467 |
| March 31, 2014 | 2.585 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Pfizer Inc. | 0.7418 |
| Eli Lilly & Co. | 1.621 |
| Merck & Co., Inc. | 1.286 |
| Bristol Myers Squibb Co. | 2.019 |
| Johnson & Johnson | 0.5771 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 35.04B |
| Total Liabilities (Quarterly) | 20.78B |
| Shareholders Equity (Quarterly) | 14.26B |
| Current Ratio | 1.488 |
| Net Debt Paydown Yield | 0.92% |